Is NiceRx a Barhemsys coupon provider?
NiceRx does not provide Barhemsys coupons, discount cards, or copay cards. We do not offer printable Barhemsys manufacturer coupons, Barhemsys discounts, rebates, Barhemsys savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your Barhemsys medication with NiceRx.
Barhemsys patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Barhemsys cheaper if I have insurance?
How much does Barhemsys cost without insurance?
Barhemsys prices without insurance will vary by retailer. As a guide, Barhemsys intravenous solution (5 mg/2 mL) will typically cost around $460 for 20 milliliters.
How much does Barhemsys cost with insurance?
Your individual healthcare plan will determine the copay of Barhemsys with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.
What is Barhemsys?
Barhemsys is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Acacia Pharma Inc. It is a dopamine-2 antagonist used in adults for:
- Prevention of postoperative nausea and vomiting (PONV), alone or with an antiemetic of a different class
- Treatment of PONV in patients who have or have not received antiemetic prophylaxis with an agent of a different class
PONV is a common complication of surgery. It occurs in 30% of surgical patients and up to 80% of high-risk patients. Barhemsys is not recommended for use in pediatric patients.
What doses of Barhemsys are available?
Barhemsys is available in injection form, in the following doses: 5 mg/2 mL in a single-dose vial.
The recommended dose for the prevention of PONV, either alone or with another antiemetic is 5 mg as a single intravenous dose over 1 to 2 minutes at the time of induction of anesthesia. For the treatment of PONV, the recommended dose is 10 mg as a single intravenous dose over 1 to 2 minutes if nausea and/or vomiting occur after a surgical procedure.
Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Barhemsys active ingredients
The active ingredient of Barhemsys is amisulpride, a selective dopamine-2 (D2) and dopamine-3 (D3) receptor, antagonist.
Barhemsys side effects
The most common side effects of Barhemsys in clinical trials compared to placebo include:
- Increased blood prolactin concentrations
- Procedural hypotension
- Abdominal distension
- Infusion site pain
In rare instances, Barhemsys can cause more serious adverse effects. These can include:
- Dose-and concentration-dependent prolongation of the QT interval. Do not take Barhemsys if you have congenital long QT syndrome or are taking droperidol. ECG monitoring is advised if you have arrhythmias/cardiac conduction disorders, electrolyte abnormalities such as hypokalemia or hypomagnesemia, congestive heart failure, or if you are taking ondansetron or if you have other medical conditions known to prolong the QT interval
Your doctor will assess the benefits of using Barhemsys against your risk of adverse reactions. Patients are encouraged to report negative side effects or adverse events of Barhemsys to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Barhemsys drug interactions
Barhemsys can interact with other medications. These include:
- Reciprocal antagonism occurs between dopamine agonists such as levodopa and Barhemsys
This list is not exhaustive and other prescription drugs may interact with Barhemsys.
You should not use Barhemsys if you:
- Have a known hypersensitivity to the active ingredient amisulpride
- Are allergic to any of the other ingredients in Barhemsys
- Have a severe renal impairment (eGFR < 30 mL/min/1.73 m²)
- Are pregnant or are planning to become pregnant
Talk to your doctor before using Barhemsys if you:
- Are taking any of the medications that could interact with Barhemsys
- Are breastfeeding or are planning to breastfeed – There are no known effects on milk production (lactation). However, a lactating woman should pump and discard breast milk for 48 hours after treatment
Barhemsys is the trademark brand name for amisulpride manufactured by Acacia Pharma Inc. A generic version of amisulpride is available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Barhemsys savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.